Engineering for Cancer Therapies
-
Johns Hopkins study reveals E-cadherin’s role in breast cancer spread, challenging previous assumptions The scientific community has long thought that a protein called E-cadherin acts as a “glue” to prevent… Read More
-
Our cells have a remarkable ability to move through our bloodstream, organs, and tissues—all of which contain fluids. A new Johns Hopkins University study offers important insights into how cells… Read More
-
Cell migration is a critical contributor to the metastasis of cancer cells. Johns Hopkins researchers have discovered that reducing levels of a key epigenetic protein called MLL1 in tumors can… Read More
-
Scientists Identify Potential New Immune System Target to Head off the Spread of Breast Cancer Cells
In a study using human breast cancer cells, scientists say they have potentially identified immune system white blood cells that appear to be the closest neighbors of breast cancer cells… Read More
-
Johns Hopkins team combines radionuclide-carrying antibodies and nanoparticles to enhance radiation delivery. Researchers from the Whiting School of Engineering’s Department of Chemical and Biomolecular Engineering and Institute for NanoBioTechnology have… Read More
-
Photo courtesy of Johns Hopkins Medicine Sickle cell disease is caused by an inherited genetic mutation. Current gene therapies are complex, time-consuming, and risky, with some clinical trials revealing serious… Read More
